a public good project by the
Synthesis
Company
of California

© 2026

Jennifer Kendall‐Dupont | doi.page

0 works0 citations0 h-index

Jennifer Kendall‐Dupont

Institute for Research in Immunology and Cancer(CA)Centre Hospitalier de l’Université de Montréal(CA)

Publications by Year

Research Areas

3D Printing in Biomedical Research, Cancer Cells and Metastasis, Ovarian cancer diagnosis and treatment, Microfluidic and Bio-sensing Technologies, Innovative Microfluidic and Catalytic Techniques Innovation

Most-Cited Works

→ Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy(2015)186 cited
→ STAT1‐associated intratumoural T_H1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer(2016)55 cited
→ Microdissected Tissue vs Tissue Slices—A Comparative Study of Tumor Explant Models Cultured On-Chip and Off-Chip(2021)29 cited
→ Paraffin-embedding lithography and micro-dissected tissue micro-arrays: tools for biological and pharmacological analysis of ex vivo solid tumors(2019)26 cited
→ Fluorescence hyperspectral imaging for live monitoring of multiple spheroids in microfluidic chips(2018)20 cited
→ Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease(2020)15 cited

→ Combination of Serum Biomarkers to Differentiate Malignant From Benign Ovarian Tumours(2012)

14 cited

→ NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer(2021)14 cited

→ Spectroscopic imaging system for high-throughput viability assessment of ovarian spheroids or microdissected tumor tissues (MDTs) in a microfluidic chip(2016)4 cited

ON-CHIP TRAPPING AND VIABILITY ASSESSMENT OF SUBMICROLITER PRIMARY TISSUES FOR PERSONALIZED TREATMENT OF OVARIAN CANCER(2013)